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ABSTRACT 
Objectives: Primordial prevention of chronic disease is of clinical 
and  public  health  importance.  Considering  the  fetal  onset  of 
atherosclerosis,  we  aimed  to  determine  the  cord  blood  level  of 
lipoproteins and apolipoproteins as well as their correlation with 
birth weight and gestational age. 
Methods: This cross-sectional study comprised 100 healthy Indian 
newborns. Ten ml. of cord blood was collected from placental end 
of umbilical vein. Serum was separated by centrifugation and ana-
lyzed on the same day for lipid profile including total cholesterol 
(TC),  triglycerides  (TG),  high  density  lipoprotein-  cholesterol 
(HDL-C),  very  low  density  lipoprotein-cholesterol  (VLDL)  and 
low density lipoprotein- cholesterol (LDL-C), apolipoproteins A-I 
and B (ApoA-I, ApoB). Atherogenic index (AI) was calculated as 
the ratio of ApoB to ApoA-I.  
Results: Cord blood of female newborns had higher TC, HDL-C, 
LDL-C, Apo A-I, Apo B and AI as compared to male newborns, 
whereas  TG  and  VLDL-C  were  higher  in  male  than  in  female 
newborns. Significant positive correlation was observed between 
cord blood Apo A-I and HDL-C (r= 0.45, p<0.01), and between 
cord blood Apo-B and LDL-C (r= 0.44, p<0.01). Non-significant 
inverse correlation was observed between Apo A-I and ApoB with 
gestational  age.  There  was  a  significant  inverse  correlation  be-
tween TG and gestational age (r= –0.197, p <0.05). Positive non-
significant correlation was observed between AI and birth weight 
(r=0.046, p>0.05). 
Conclusions: These findings are another confirmatory evidence 
for the association of prenatal factors with cord blood lipid pro-
file, and can serve as starting point for studying lipid transport 
system changes during early life. 
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INTRODUCTION 
Atherosclerosis, a major cause of cardiovas-
cular disease, is a process that begins early in life 
and progresses silently for decades.
1 Epidemiol-
ogical studies reveal a strong independent rela-
tionship  between  serum  cholesterol  and  coro-
nary  heart  disease.
2  Maternal  hypocholes-
terolemia  has  been  reported  to  enhance  early 
atherogenesis  and  marked  increase  in  fatty 
streaks in human fetuses.
3 
A fetus needs a considerable amount of cho-
lesterol for development of tissues and organs. 
After  birth,  human  lipid  transport  system  is 
transformed from one containing low levels of 
very  low  density  lipoprotein  (VLDL)  and  low 
density lipoprotein- cholesterol (LDL-C) to adult 
pattern  with  relatively  high  levels  of  LDL-C 
which continues to increase with age. Cord sera 
have  been  demonstrated  to  contain  all  well-
characterized adult lipoproteins and apolipopro-
teins.
4 Fetal growth restriction is associated with 
a chronic pattern of atherogenic lipoprotein me-
tabolism.  The  relative  amount  of  apolipopro-
teins A-I and B (ApoA-I, ApoB) is important. 
Atherogenic index (AI), i.e. the ratio of ApoB to 
ApoA-I, is found to track closely during the first Cord blood lipid profile in Indian newborns 
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year  of  life.
5  Abnormal  lipoprotein  profiles  in 
childhood  persist  into  adult  life  and  elevated 
Apo B levels in young adults have been linked to 
atherosclerosis in later life.
5 Young age can be  
viewed  as  an  opportunity  to  begin  preventive 
interventions  to  change risk  factors  for  cardio-
vascular  risk.  Hence  the  present  study  was 
planned to analyze cord blood lipoproteins and 
apolipoproteins  levels  and  to  correlate  them 
with birth weight and gestational age. 
 
METHODS 
The present study was conducted in the De-
partment of Biochemistry in collaboration with 
Department  of  Obstetrics  and  Gynecology, 
Pt.B.D.Sharma  PGIMS,  Rohtak,  India.  The 
study  protocol  was  approved  by  the  institute's 
Committee  on  Human  Research  and  the  ex-
periments conformed to institutional standards. 
Mothers gave their informed consent. The study 
group  consisted  of  100  healthy  neonates  born 
following healthy normotensive pregnancy and 
normal term-delivery. 
Ten  milliliter  of  cord  blood  was  collected 
from the placental end of umbilical vein. Serum 
was separated by centrifugation and analyzed on 
the  same  day  for  lipid  profile,  including  total 
cholesterol (TC), triglycerides (TG), HDL cho-
lesterol (HDL-C), VLDL and LDL-C, as well as 
ApoA-I and ApoB.
 6-11 AI was calculated as the 
ratio of ApoB to ApoA-I.
12 
Statistical analysis: Continuous data was com-
puted as mean + standard deviation (SD). The 
Student’s  t-test  was  applied  for  comparison  of 
mean  values.  The  relationship  of  cord  blood  
lipid  profile  with  birth  weight  and  gestational 
age was determined by regression analysis. Data 
were analyzed using the SPSS statistical package 
version 14.0 for windows (SPSS Inc., Chicago, 
USA). The significance level was set at p<0.05. 
 
RESULTS 
In female newborns, TC, LDL-C (p<0.01, in 
both  parameters)  and  HDL-C  (p<0.05)  were 
significantly higher in comparison to their male 
counterparts.  TG  and  VLDL-C  levels  were 
higher  in  male  newborns  as  compared  to  fe-
males  but  the  difference  was  not  statistically 
significant (Table 1).  
Significant positive correlation was observed 
between  cord  blood  Apo  A-I  and  HDL-C  (r= 
0.45,  p<0.01),  as  well  as  between  Apo-B  and 
LDL-C (r= 0.44, p<0.01). 
Table  2  presents  the  relationship  of  cord 
blood lipid profile with birth weight and gesta-
tional  age.  Apo  A-I  and  Apo-B  had  a  non-
significant  inverse  correlation  with  gestational 
age. TG had significant inverse relationship with 
gestational  age(r=  –0.197,  p  <0.05).  A  non-
significant  positive  association  was  observed 
between AI and birth weight (r=0.046). 
 
Table 1. Mean (SD) level of lipid   profile in cord blood (mg/dL) 
 
   Total  Male  Female 
  n=100  n=50  n=50 
Total Cholesterol (mg/dL)  73.64+21.61  68.38+16.69  78.90+24.68* 
HDL-C (mg/dL)  23.25+7.66  21.66+6.78  24.84+8.22** 
LDL-C (mg/dL)  41.81+17.88  37.76+6.78  45.86+18.95** 
VLDL-C (mg/dL)  12.81+11.08  13.35+12.45  12.16+9.47
+ 
Triglycerides (mg/dL)  33.75+16.39  34.32+17.58  33.18+15.28
+ 
Apolipoprotein A-I (mg/dL)  67.08+17.28  63.52+15.30  70.64+18.52
+ 
Apolipoprotein B (mg/dL)  32.15+16.10  28.54+13.78  35.76+17.52* 
Atherogenic index                                                                                           0.47+0.16  0.45+0.15  0.49+0.16**    Cord blood lipid profile in Indian newborns 
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   Table 2. Relationship of apolipoproteins and triglycerides with gestational age 
  r  p value 
Apo A-I   -0.056  NS 
Apo-B   -0.039  NS 
Triglycerides  -0.197  <0.05 
    NS: Not significant 
 
DISCUSSION 
In this study, cord blood levels of TC, HDL-
C  and  LDL-C  were  significantly  higher  in  fe-
males than in males. Although cord blood levels 
of  TG  and  VLDL-  C  were  higher  in  females 
than in males, but this difference was not statis-
tically significant. Our findings are in agreement 
with some previous studies
13,14 and suggest that 
gender-related factors might influence lipid lev-
els from fetal period. 
It is well-documented that low Apo A- I and 
/  or  increased  Apo  B  are  associated  with  in-
creased  cardiovascular  risk.  Elevated  LDL-  C 
and Apo B levels in young adults are linked with 
cardiovascular disease in later life.
12 In the pre-
sent study, Apo A-I, ApoB and AI were higher 
in female cord blood as compared to males. In 
cord blood, all well-characterized adult apolipo-
proteins  with  reduced  ApoB  have  been  re-
ported
.4 Moreover, we found significant positive 
correlation  between  Apo  A-I  and  HDL-C,  as 
well as between ApoB and LDL-C. Our findings 
are in agreement with those reported by Sattar et 
al.
15  Gender-based  differences  in  lipoprotein 
metabolism have been reported to be implicated 
in lipoprotein metabolism.
13,14,16  
A  link  between  low  birth  weight  and  adult 
onset atherosclerosis has been reported in litera-
ture, where elevated Apo B levels were observed 
in growth-retarded fetuses.
17 Levels of Apo A-I 
and ApoB have been reported to be measured in 
fetuses with normal growth, data are available 
regarding circulating fetal levels of apolipopro-
teins in growth retarded fetuses. These findings 
indicate that apo-B levels are elevated in growth-
retarded fetuses and might be considered as con-
firmatory evidence on a link between low birth 
weight  and  adult  onset  atherosclerosis. 
Radunovicetal et al. reported significant differ-
ences in ApoB level and  its ratio to Apo A-1, 
i.e. AI in growth-retarded fetuses as compared 
to  normal  fetus.  They  also  reported  that  fetal 
Apo A-I and ApoB levels do not correlate with 
gestational age.
 18 In the present study, Apo A-I 
and  ApoB  levels  had  non-significant  inverse 
association  with  gestational  age,  whereas  TG 
had a significant negative correlation with gesta-
tional age. Fetal growth retardation establishes a 
life-long  irreversible  atherogenic  profile  and 
those  individuals  with  a  history  of  low  birth 
weight are reported to have an atherogenic pro-
file.
18 In the present study, AI showed positive 
correlation with birth weight. Barker et al. have 
reported  an  inverse  correlation  of  birth  weight 
and  neonatal  abdominal  circumference  with 
adult serum cholesterol, LDL-C and Apo B lev-
els, suggesting that the association between ab-
errant  lipoprotein  metabolism  and  low  birth 
weight is present by the time intrauterine growth 
restriction is clinically evident.
  19 Other reports 
have  demonstrated  that  abnormal  lipoprotein 
profiles  in  childhood  persist  into  adult  life.
20,21 
Furthermore,  the  prevalence  and  severity  of 
carotid  artery  atherosclerosis  in  later  life  are 
linked to lower birth weights.
22A Swedish cohort 
study  found  a  strong  relationship  between  im-
paired fetal growth and subsequent cardiovascu-
lar mortality.
23 These findings indicate that fetal 
growth  restriction  is  associated  with  a  chronic 
pattern  of  atherogenic  lipoprotein  metabolism. 
Lack  of  any  significant  difference  in  total  TG 
levels  between  the  two  groups  in  the  present 
study supports a constitutional basis for the dif-
ferences in apolipoprotein metabolism, observed 
in our study.  
Immunochemical  studies  of  the  cord  lipid 
transport system have shown that all the well-
characterized apolipoproteins are present in cord 
blood, although at lower level than that found in 
the  normal  adult.
  McConathy  et  al.  reported 
existence of all well-characterized adult apolipo-
proteins in cord blood, with Apo B levels most 
reduced.
 4 In the present study, we also observed 
that apo B level were most reduced of the apoli-
poprotein parameters in cord blood, and AI was 
higher  in  cord  blood  of  female  newborns  as 
compared to their male counterparts.  
Fetus needs a considerable amount of choles-
terol  for  development  of  tissues  and  organs, 
there should be no surplus cholesterol.
24 How-Cord blood lipid profile in Indian newborns 
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ever, high AI is found to track closely during the 
first  year  of  life.
25  Thus,  it  is  suggested  that 
atherogenic  milieu occurring during  pregnancy 
persists into adulthood and fetal growth retarda-
tion is associated with adult atherosclerosis.  
 
CONCLUSIONS 
Roots  for  many  adult  diseases,  including 
atherosclerotic cardiovascular diseases, begin in 
childhood and clustered risk factors track from 
childhood  to  adulthood.  These  factors  can  be 
altered  favorably  and  can  be  modified  by  pre-
ventive  interventions and  early  lifestyle  related 
factors.  Establishment  of  references  values  for 
lipoprotein  and  apolipoprotein  would  facilitate 
comparison between different studies. Data on 
lipoproteins, apolipoprotein presented here can 
serve as starting point for studying lipid trans-
port  system  changes  and  thyroid  hemostasis 
during  early  days  and  months  of  life  and  for 
correlating  them  with  cardiovascular  disease. 
These  findings  are  another  confirmatory  evi-
dence for the association of prenatal factors with 
cord blood lipid profile, and can serve as starting 
point for studying lipid transport system changes 
during early life. 
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